Sanger Institute Detects Chromosomal Rearrangements in Breast Cancers on Illumina Platform

The study demonstrates the ability of next-gen sequencing technologies to detect chromosomal rearrangements at a level that previous sequencing technologies and cytogenetics could not do.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.